<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04011813</url>
  </required_header>
  <id_info>
    <org_study_id>2014 HYPOTAURINE</org_study_id>
    <nct_id>NCT04011813</nct_id>
  </id_info>
  <brief_title>Hypotaurine Supplementation Benefits in Cryopreservation</brief_title>
  <acronym>HYPOTAURINE</acronym>
  <official_title>Official Title: Hypotaurine Supplementation in Freezing and Preparation Media Improves Human Sperm DeoxyriboNucleic Acid (DNA) and Fertilizing Ability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Université d'Auvergne, Institut National de la Santéet de la Recherche Médicale</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Université d'Auvergne, Centre National de la Recherche Scientifique</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Clermont-Ferrand, Hematology laboratory</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although it is widely used, slow freezing can induce strong functional and nuclear spermatic
      alterations reducing the chances of pregnancy. The study objective is to determinate the
      effects of the combination of hypotaurine supplementation and spermatozoa selection by
      Density Gradient Centrifugation (DGC) on human sperm functions and DNA quality during a
      freezing-thawing cycle.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective study was performed on surplus semen after a density gradient
      centrifugation-frozen-thawing cycle. Samples were obtained from men undergoing routine semen
      analysis at the Center for Reproductive Medicine. Spermatozoa were selected by density
      gradient centrifugation, washed and frozen using a programmable device. Each step was
      performed in parallel with (H+ arm) or without (H- arm) 50mM hypotaurine supplementation.
      After thawing, investigator team compared for both conditions the total and progressive
      mobility, vitality, integrity of the acrosome, markers of Protein Kinase A (PKA) dependent
      capacitation intracellular signaling pathway and nuclear quality by measuring chromatin
      packaging, DNA fragmentation and oxidation and vacuoles presence in the spermatozoa head.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2014</start_date>
  <completion_date type="Actual">May 1, 2019</completion_date>
  <primary_completion_date type="Actual">August 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>chromatin packaging labelled using aniline blue and chromomycin A3</measure>
    <time_frame>Day 0</time_frame>
    <description>Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of chromatin packaging labelled using aniline blue and chromomycin A3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DNA fragmentation using TUNEL assay</measure>
    <time_frame>Day 0</time_frame>
    <description>Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of DNA fragmentation using TUNEL assay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DNA oxidation assessed by 8-OHdG immunodetections</measure>
    <time_frame>Day 0</time_frame>
    <description>Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of DNA oxidation assessed by 8-OHdG immunodetections</description>
  </primary_outcome>
  <primary_outcome>
    <measure>vacuoles presence in the spermatozoa head using Motile Sperm Organelle Morphology Examination (MSOME)</measure>
    <time_frame>Day 0</time_frame>
    <description>Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of vacuoles presence in the spermatozoa head using Motile Sperm Organelle Morphology Examination (MSOME)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>vitality using Eosin Nigrosin</measure>
    <time_frame>Day 0</time_frame>
    <description>Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of vitality using Eosin Nigrosin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>motility total and progressive</measure>
    <time_frame>Day 0</time_frame>
    <description>Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of motility total and progressive</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>integrity of the acrosome using Fluorescein IsoThioCyanate-Pisum Sativum Agglutinin (FITC-PSA) labelling</measure>
    <time_frame>Day 0</time_frame>
    <description>Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of integrity of the acrosome using Fluorescein IsoThioCyanate-Pisum Sativum Agglutinin (FITC-PSA) labelling</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>markers of PKA-dependent capacitation intracellular signaling pathway assessing western blot</measure>
    <time_frame>Day 0</time_frame>
    <description>Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of markers of PKA-dependent capacitation intracellular signaling pathway assessing western blot</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">33</enrollment>
  <condition>Cryopreservation</condition>
  <condition>Human Spermatozoa Parameters</condition>
  <condition>Hypotaurine Supplementation</condition>
  <condition>Spermatozoa DNA Alterations</condition>
  <arm_group>
    <arm_group_label>Control arm, &quot;H-&quot;</arm_group_label>
    <description>semen treated without hypotaurine supplementation in density gradient centrifugation, washing and cryopreservation media</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental arm, &quot;H+&quot;</arm_group_label>
    <description>semen treated with a 50mM hypotaurine supplementation in density gradient centrifugation, washing and cryopreservation media</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypotaurine : antioxidant and osmoregulator</intervention_name>
    <description>Hypotaurine has protective effects on sperm motility, capacitation and acrosome reaction and reduces apoptotic markers.
Hypotaurine (50mM) was added in density gradient centrifugation, washing and cryopreservation media washing and cryopreservation media before spermatozoa freezing</description>
    <arm_group_label>Experimental arm, &quot;H+&quot;</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Men undergoing routine semen analysis at the Center for Reproductive Medicine
      </textblock>
    </study_pop>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  None

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florence BRUGNON, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 21, 2019</study_first_submitted>
  <study_first_submitted_qc>July 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2019</study_first_posted>
  <last_update_submitted>July 3, 2019</last_update_submitted>
  <last_update_submitted_qc>July 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cryopreservation</keyword>
  <keyword>density gradient centrifugation</keyword>
  <keyword>DNA fragmentation, oxidation, chromatin packaging</keyword>
  <keyword>antioxidant hypotaurine supplementation</keyword>
  <keyword>cryo-capacitation</keyword>
  <keyword>human spermatozoa fertilizing ability</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antioxidants</mesh_term>
    <mesh_term>Hypotaurine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

